NV Industriebank LIOF

Total investments

23

Average round size

6M

Portfolio companies

21

Rounds per year

0.47

Lead investments

3

Follow on index

0.09

Exits

3

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareManufacturingMedical DeviceMedicalLife ScienceTherapeuticsChemicalAgricultureAlternative Medicine

Summary

NV Industriebank LIOF is the famous Corporate Investor, which was founded in 1975. The company was established in Europe in The Netherlands. The leading representative office of defined Corporate Investor is situated in the Maastricht.

The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2016. Comparing to the other companies, this NV Industriebank LIOF performs on 1 percentage points more the average number of lead investments. The important activity for fund was in 2011. Despite it in 2019 the fund had an activity. Considering the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The typical case for the fund is to invest in rounds with 3 participants. Despite the NV Industriebank LIOF, startups are often financed by Nedermaas Hightech Ventures, Ysios Capital, Thuja Capital. The meaningful sponsors for the fund in investment in the same round are Limburg Ventures, Nedermaas Hightech Ventures, Chemelot Ventures. In the next rounds fund is usually obtained by Health Innovation Fund, Thuja Capital, Sandbridge Capital.

The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Phenospex, FABPulous, Ekompany. For fund there is a match between the location of its establishment and the land of its numerous investments - The Netherlands. Among the most successful fund investment fields, there are Recycling, Agriculture. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
23
Lead investments
3
Exits
3
Rounds per year
0.47
Follow on index
0.09
Investments by industry
  • Biotechnology (7)
  • Medical (6)
  • Health Care (5)
  • Therapeutics (3)
  • Agriculture (3)
  • Show 28 more
Investments by region
  • Netherlands (16)
  • Belgium (1)
  • The Netherlands (6)
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
29M
Group Appearance index
0.96
Avg. company exit year
5
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Corporis Medical 07 Dec 2023 Commercial, Medical Device, Medical Early Stage Venture 4M Maastricht, Limburg, The Netherlands
Events.com 06 Nov 2012 Software, SaaS, PaaS, Event Management, Events, Ticketing, Developer APIs, Mobile Advertising Early Stage Venture 2M United States, California, San Diego
FABPulous 11 Jan 2010 Biotechnology, Health Care, Medical Early Stage Venture 0 The Netherlands, Limburg, Netherlands

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.